41 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
Upcoming Investor Event
Verve plans to participate in a fireside chat at the RBC Global Healthcare Conference on Wednesday, May 15, 2024, at 8:00 a.m
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
”) by the U.K. Medicines and Healthcare products Regulatory Agency (“MHRA”) and Health Canada for VERVE-102, with the Heart-2 Phase 1b clinical trial
8-K
EX-1.1
w2rlpcp6ii1017e7lt8v
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
h97oud0y7
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
6emzt 9oertobin8mq
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
EX-99.1
tcp9h m38
7 Nov 23
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
v0ti6xo2a88s
15 May 23
Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results
7:00am